SCHEDULE: Armistice Capital Discloses Verastem Stake

Armistice Capital, LLC and Steven Boyd have reported a beneficial ownership of 5.23% in Verastem, Inc. common stock as of March 31, 2026.

Summary

• Armistice Capital, LLC and Steven Boyd have filed an amendment to their Schedule 13G, reporting their beneficial ownership of Verastem, Inc. common stock.
• As of March 31, 2026, the reporting persons collectively beneficially own 4,592,000 shares of Verastem, Inc. common stock.
• This ownership represents 5.23% of the class of securities.
• Armistice Capital, LLC acts as the investment manager for Armistice Capital Master Fund Ltd., the direct holder of the shares.
• Steven Boyd, as the managing member of Armistice Capital, LLC, may also be deemed to beneficially own these shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership and does not provide new operational or financial information about the company itself.

Positives

• Armistice Capital, LLC and Steven Boyd have disclosed a significant stake (5.23%) in Verastem, Inc., indicating investor confidence or strategic interest.
• The filing is an amendment to a Schedule 13G, suggesting ongoing monitoring and reporting of ownership, which is a standard compliance practice.

Negatives

• The filing does not contain any negative financial results or operational challenges for Verastem, Inc. itself, as it is a disclosure of ownership by a third party.

Risks

• The filing does not explicitly mention risks related to Verastem, Inc.'s operations. The primary risk is associated with the investment itself, where the value of the shares held by Armistice Capital could fluctuate.
• Potential for increased scrutiny or activism from Armistice Capital, given their significant ownership stake.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding Verastem, Inc.'s future performance.

Management Comments

• Armistice Capital, LLC is the investment manager of Armistice Capital Master Fund Ltd., the direct holder of the Shares, and pursuant to an Investment Management Agreement, Armistice Capital exercises voting and investment power over the securities of the Issuer held by the Master Fund and thus may be deemed to beneficially own the securities of the Issuer held by the Master Fund.
• Mr. Boyd, as the managing member of Armistice Capital, may be deemed to beneficially own the securities of the Issuer held by the Master Fund.
• The Master Fund specifically disclaims beneficial ownership of the securities of the Issuer directly held by it by virtue of its inability to vote or dispose of such securities as a result of its Investment Management Agreement with Armistice Capital.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes in publicly traded companies. This filing indicates Armistice Capital's strategic interest in Verastem, Inc., which could signal a belief in the company's future prospects or a desire for influence.

Stakeholder Impact

• Shareholders: May view the increased stake by Armistice Capital as a positive sign of investor interest, or potentially as a precursor to activist involvement.
• Management of Verastem, Inc.: May need to engage with Armistice Capital regarding their investment strategy and the company's direction.

Next Steps

• Armistice Capital, LLC and Steven Boyd will continue to monitor their investment in Verastem, Inc. and may file amendments to this Schedule 13G if their beneficial ownership changes significantly.

Key Dates

Keywords

Schedule 13G, Verastem, Inc., Armistice Capital, LLC, Steven Boyd, Beneficial Ownership, Common Stock, SEC Filing, Investment Management